Skip to content
verana-health-logo-inverted
  • Clinicians
    • MIPS Advisory Offerings
    • Practice Insights
    • Verana Trial Connect
    • Verana Quality Measures
  • Life Sciences
    • Clinical Development
    • HEOR & Medical Affairs
    • Commercialization
  • Research
  • Therapeutic Area
    • Oncology
      • Acute Myeloid Leukemia
      • Breast Cancer
      • Chronic Lymphocytic Leukemia
      • Colorectal Cancer
      • Follicular Lymphoma
      • Large B-Cell Lymphoma
      • Lung Cancer
      • Marginal Zone Lymphoma
      • Melanoma
      • Multiple Myeloma
      • Myelodysplastic Syndrome
      • Ovarian Cancer
    • Ophthalmology
      • Anti-VEGF
      • Diabetic Retinopathy
      • Dry Eye Disease
      • Cataracts
      • Geographic Atrophy
      • Glaucoma
      • Neovascular AMD
      • Retinitis Pigmentosa
      • Thyroid Eye Disease
      • Uveitic Macular Edema
      • Qdata Explorer
    • Urology
      • Benign Prostatic Hyperplasia
      • Bladder Cancer
      • Prostate Cancer
    • Neurology
      • Multiple Sclerosis
      • Parkinson’s Disease
      • Spinal Muscular Atrophy
  • Solutions
    • Clinical Research Solutions
      • Trial Design
      • Protocol Optimization & Site Selection
      • Patient Recruitment
      • Prospective Evidence Generation (PEG)
    • Clinical Trials
      • Site Explorer
    • Market Insights
      • Market Tracking
      • Brand Switching
      • Prescriber Mapping
    • RWE Studies
      • Patient Segmentation
      • Safety Studies
      • Natural History of Disease / Disease Progression
      • Comparative Effectiveness
      • Treatment Patterns & Outcomes
      • Healthcare Resource Utilization (HCRU) Cost
    • Phase IV Studies / Surveillance
  • About Us
    • About
      • Evolve Registry
    • Team
    • Press
    • Blog
    • Careers
    • Partners
      • Societies
      • CROs
      • Technology and Data
    • Privacy
      • Privacy Policy
      • Patient Privacy
Contact Us

Best Practices in the Curation and Use of Real-world Data in the Regulatory Pathway

Read More

Continuous maintenance (Maint) capecitabine (Cape) dosing for colorectal (CRC) and pancreatic cancers (PC): A single-institution, retrospective, real-world study

Read More

Reality Check: Real-world evidence to support therapeutic development in hematologic malignancies

Read More

Development of a Precise, Clinically Relevant, Digital Classification Schema for Cancer

Read More

A Patient-Reported Outcome Instrument to Assess Symptom Burden and Predict Survival in Patients with Advanced Cancer: Flipping the Paradigm to Improve Timing of Palliative and End-of-Life Discussions and Reduce Unwanted Health Care Costs

Read More

Predictive value of the patient reported outcome “living with cancer” instrument on overall survival in advanced cancer patients: A tool for guiding timing of palliative care consultations

Read More

Identifying latent factors in the Living With Cancer (LWC) patient-reported outcomes (PRO) tool for patients with advanced malignancies

Read More

Are patients with cancer concerned about burdening their families?

Read More

Validation of the Living With Cancer (LWC) PRO tool for identifying patients (pts) with cancer appropriate for end-of-life care consultations

Read More

A Patient-Reported Outcome Instrument to Facilitate Timing of End-of-Life Discussions among Patients with Advanced Cancers

Read More
Older Posts »

Recent Posts

  • Verana Health Delivers Powerful Update to RWD Bladder Cancer Database
  • Verana Health Introduces Expanded Ovarian Cancer Dataset
  • Verana Health Transforms Site Selection and Patient Enrollment in Clinical Trials
  • Verana Health Introduces World’s Largest Real-World Dataset for Prostate Cancer
  • New Verana Health AI Agent Boosts Efficiency and Compliance in MIPS Submissions
verana-health-logo-inverted

© 2026 Verana Health. All Rights Reserved.

San Francisco
New York
Knoxville
  • Privacy Policy
  • Cookie Policy
Back to Top